業績

HOME > 業績 > 2021年

業績

HOME > 業績 > 2021年

2021年

原著論文: 症例報告を含む

1.	Kato H, Takeuchi M, Horita N, Ishido T, Mizuki R, Kawagoe T, Shibuya E, Yuda K, Ishido M, Mizuki Y, Hayashi T, Meguro A, Kirino Y, Minegishi K, Nakano H, Yoshimi R, Kurosawa M, Fukumoto T, Takeno M, Hotta K, Kaneko T, Mizuki N: HLA-A26 is a risk factor for Behçet's disease ocular lesions. Mod Rheumatol, 31: 214-218, 2021.
2.	Chen H, Horita N, Matsumoto H, Namkoong H, Hara Y, Kobayashi N, Kaneko T: ABO blood group as a risk factor for tuberculosis: a network meta-analysis. Int J Infect Dis, 104: 701-707, 2021.
3.	Tateishi Y, Horita N, Namkoong H, Enomoto T, Takeda A, Kaneko T: Postoperative radiotherapy for completely resected Masaoka/Masaoka-Koga stage II/III thymoma improves overall survival: An updated meta-analysis of 4,746 patients. J Thorac Oncol, 16: 677-685, 2021.
4.	Kobayashi N, Katakura S, Kamimaki C, Somekawa K, Fukuda N, Tanaka K, Watanabe K, Horita N, Hara Y, Piao H, Kaneko T: Resistance mechanisms of epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer patients: A meta-analysis. Thorac Cancer, 12: 1096-1105, 2021.
5.	Shinoda M, Shinkai M, Hara Y, Tomaru K, Manabe S, Murakami S, Saito H, Kobayashi N, Miyazawa N, Nishikawa M, Kaneko T: Efficacy and safety of carboplatin and pemetrexed followed by maintenance with pemetrexed for elderly patients with advanced non-squamous non-small cell lung cancer: A single-arm, open-label, multicenter, phase II study. Asia Pac J Clin Oncol, 17: 486-494, 2021.
6.	Horita N, Fukuda N, Kaneko T: Atezolizumab for PD-L1-Selected Patients with NSCLC. N Engl J Med, 384: 583-584, 2021.
7.	Hara Y, Nakashima K, Nagasawa R, Murohashi K, Tagami Y, Aoki A, Okudela K, Kaneko T: Heme oxygenase-1 in patients with interstitial lung disease: A review of the clinical evidence. Am J Med Sci, 362: 122-129, 2021.
8.	Ebina-Shibuya R, Namkoong H, Horita N, Kato H, Hara Y, Kobayashi N, Kaneko T: Hydroxychloroquine and chloroquine for treatment of coronavirus disease 19 (COVID-19): a systematic review and meta-analysis of randomized and non-randomized controlled trials. J Thorac Dis, 13: 202-212, 2021.
9.	Lin X, Deng H, Chen L, Wu D, Chen X, Yang Y, Chen T, Xie X, Xie Z, Liu M, Ouyang M, Qin Y, Li S, Zhong N, Gregg JP, Horita N, Song Y, Zhou C: Clinical types of checkpoint inhibitor-related pneumonitis in lung cancer patients: a multicenter experience. Transl Lung Cancer Res, 10: 415-429, 2021.
10.	Mukae H, Kaneko T, Obase Y, Shinkai M, Katsunuma T, Takeyama K, Terada J, Niimi A, Matsuse H, Yatera K, Yamamoto Y, Azuma A, Arakawa H, Iwanaga T, Ogawa H, Kurahashi K, Gon Y, Sakamoto H, Shibata Y, Tamada T, Nishioka Y, Haranaga S, Fujieda S, Miyashita N, Mochizuki H, Yokoyama A, Yoshihara S, Tamaoki J; JRS guidelines committee for the management of cough and sputum: The Japanese respiratory society guidelines for the management of cough and sputum (digest edition). Respir Investig, 59: 270-290, 2021.
11.	Horita N, Katakura S, Takeshi K: Combination treatment options for small-cell lung cancer. Lancet Oncol, 22: e83, 2021.
12.	Kubo S, Ohtake N, Miyakawa K, Jeremiah SS, Yamaoka Y, Murohashi K, Hagiwara E, Mihara T, Goto A, Yamazaki E, Ogura T, Kaneko T, Yamanaka T, Ryo A: Development of an Automated Chemiluminescence Assay System for Quantitative Measurement of Multiple Anti-SARS-CoV-2 Antibodies. Front Microbiol, 11:628281, 2021.
13.	Fukumoto T, Horita N: Single or dual immune checkpoint inhibitor as adjuvant therapy in advanced melanoma. Eur J Cancer, 147: 140-141, 2021.
14.	Chen H, Hara Y, Horita N, Saigusa Y, Kaneko T: An Early Screening Tool for Discharge Planning Shortened Length of Hospital Stay for Elderly Patients with Community-Acquired Pneumonia. Clin Interv Aging, 16: 443-450, 2021.
15.	Ishii M, Horita N, Takeuchi M, Matsumoto H, Ebina-Shibuya R, Hara Y, Kobayashi N, Mizuki N, Kaneko T: Inhaled Corticosteroid and Secondary Glaucoma: A Meta-analysis of 18 Studies. Allergy Asthma Immunol Res, 13: 435-449, 2021.
16.	Eriguchi T, Takeda A, Tateishi Y, Tsurugai Y, Sanuki N, Ebinuma H, Horita N: Comparison of stereotactic body radiotherapy and radiofrequency ablation for hepatocellular carcinoma: Systematic review and meta-analysis of propensity score studies. Hepatol Res, 51: 813-822, 2021.
17.	Oshikata C, Watanabe M, Ishida M, Kobayashi S, Hashimoto K, Kobayashi N, Yamazaki A, Konuma R, Kaneko T, Kamata Y, Kuriyama S, Yanai M, Tsurikisawa N: Association between Temporary Housing Habitation after the 2011 Japan Earthquake and Mite Allergen Sensitization and Asthma Development. Int Arch Allergy Immunol, 182: 949-961, 2021.
18.	Tsurikisawa N, Oshikata C, Watanabe M, Fukuda N, Yamaguchi T, Kiyohara H, Kaneko T: Clinical Features of Patients with Active Eosinophilic Granulomatosis with Polyangiitis Successfully Treated with Mepolizumab. Int Arch Allergy Immunol, 182: 744-756, 2021.
19.	Tateishi Y, Takeda A, Horita N, Tsurugai Y, Eriguchi T, Kibe Y, Sanuki N, Kaneko T: Stereotactic body radiotherapy with a high maximum dose improves local control, cancer-specific death and overall survival in peripheral early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys, 111: 143-151, 2021.
20.	Fujiwara Y, Horita N, Namkoong H, Galsky MD: The effect of adding immune checkpoint inhibitors on the risk of pneumonitis for solid tumours: a meta-analysis of phase III randomised controlled trials. Eur J Cancer, 150: 168-178, 2021.
21.	Kamimaki C, Kobayashi N, Hirata M, Somekawa K, Fukuda N, Kubo S, Katakura S, Teranishi S, Watanabe K, Horita N, Hara Y, Yamamoto M, Kudo M, Piao H, Kaneko T: T-cell response to phytohemagglutinin in the interferon-γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non-small cell lung cancer. Thorac Cancer, 12: 1726-1734, 2021.
22.	Inoue R, Watanabe K, Saigusa Y, Hirama N, Hara Y, Kobayashi N, Kudo M, Kaneko T: Effect of coexisting advanced extrapulmonary solid cancer on progression of Mycobacterium avium complex lung disease. J Bras Pneumol, 47: e20200520, 2021.
23.	Miyake S, Higurashi T, Jono T, Akimoto T, Ogawa F, Oi Y, Tanaka K, Hara Y, Kobayashi N, Kato H, Yamashiro T, Utsunomiya D, Nakajima A, Yamamoto T, Maeda S, Kaneko T, Takeuchi I: Real-world evaluation of a computed tomography-first triage strategy for suspected Coronavirus disease 2019 in outpatients in Japan: An observational cohort study. Medicine (Baltimore), 100: e26161, 2021.
24.	Chen H, Matsumoto H, Horita N, Hara Y, Kobayashi N, Kaneko T: Prognostic factors for mortality in invasive pneumococcal disease in adult: a system review and meta-analysis. Int J Infect Dis, 11: 11865, 2021.
25.	Ushio R, Yamamoto M, Miyasaka A, Muraoka T, Kanaoka H, Tamura H, Kaneko A, Izawa A, Hirama N, Teranishi S, Manabe S, Inoue T, Shibata K, Sugiura Y, Kudo M, Kaneko T: Nivolumab-induced Vogt-Koyanagi-Harada-like Syndrome and Adrenocortical Insufficiency with Long-term Survival in a Patient with Non-small-cell Lung Cancer. Intern Med, 60: 3593-3598, 2021.
26.	Chiyako O, Maiko W, Masatsugu I, Seiichi K, Kazuhiro H, Naoki K, Akiko Y, Rumi K, Takashi S, Takeshi K, Yoichi K, Shinichi K, Masaru Y, Naomi T: Mite avoidance decreased mite-specific IgE levels and ameliorated asthma symptoms in subjects who lived in temporary housing after natural disasters. Allergol Immunopathol (Madr), 49: 171-179, 2021.
27.	Kamimaki C, Yamamoto M, Sawazumi T, Kudo M, Kaneko T: A functionally improved case of obstructive impairment caused by systemic lupus erythematosus. Breathe (Sheff), 17: 200288, 2021.
28.	Kamada K, Konno S, Kaneko T, Fukunaga K, Hasegawa Y, Yokoyama A: The effect of the outbreak of COVID-19 on respiratory physicians and healthcare in Japan: Serial nationwide surveys by the Japanese Respiratory Society. Respir Investig, 59: 792-798, 2021.
29.	Horita N, Miyagi E, Mizushima T, Hagihara M, Hata C, Hattori Y, Hayashi N, Irie K, Ishikawa H, Kawabata Y, Kitani Y, Kobayashi N, Kobayashi N, Kurita Y, Miyake Y, Miyake K, Oguri S, Ota I, Shimizu A, Takeuchi M, Yamada A, Yamamoto K, Yukawa N, Masuda M, Oridate N, Ichikawa Y, Kaneko T: Severe anaphylaxis caused by intravenous anti-cancer drugs. Cancer Med, 10: 7174-7183, 2021.
30.	Fukuda N, Horita N, Katakura S, Namkoong H, Kaneko A, Somekawa K, Tagami Y, Watanabe K, Hara Y, Kobayashi N, Kaneko T: The best regimens for chemo-naïve incurable non-squamous non-small cell lung cancer with a programmed death-ligand 1, tumor proportion score 1-49%: a network meta-analysis. Transl Lung Cancer Res, 10: 3550-3566, 2021.
31.	Chen H, Ishihara M, Horita N, Tanzawa S, Kazahari H, Ochiai R, Sakamoto T, Honda T, Ichikawa Y, Watanabe K, Seki N: Effectiveness of Cell-Free and Concentrated Ascites Reinfusion Therapy in the Treatment of Malignancy-Related Ascites: A Systematic Review and Meta-Analysis. Cancers (Basel), 13: 4873, 2021.
32.	Kimura Y, Nakai Y, Shin J, Hara M, Takeda Y, Kubo S, Jeremiah SS, Ino Y, Akiyama T, Moriyama K, Sakai K, Saji R, Nishii M, Kitamura H, Murohashi K, Yamamoto K, Kaneko T, Takeuchi I, Hagiwara E, Ogura T, Hasegawa H, Tamura T, Yamanaka T, Ryo A: Identification of serum prognostic biomarkers of severe COVID-19 using a quantitative proteomic approach. Sci Rep, 11: 20638, 2021.
33.	Hoshi M, Kobayashi N, Tanaka K, Somekawa K, Kaneko A, Izawa A, Seki K, Tagami Y, Aoki A, Fujii H, Watanabe K, Horita N, Hara Y, Matsumura M, Enaka M, Hagihara M, Kaneko T: Diagnostic utility of transbronchial biopsy for Hodgkin's lymphoma: A case study. Thorac Cancer, 12: 3281-3285, 2021.
34.	Iizuka Y, Takase-Minegishi K, Hirahara L, Kirino Y, Soejima Y, Namkoong H, Horita N, Yoshimi R, Takeuchi M, Takeno M, Mizuki N, Nakajima H: Beneficial Effects of Apremilast on Genital Ulcers, Skin Lesions, and Arthritis in Patients With Behçet's Disease: A Systematic Review and Meta-Analysis. Mod Rheumatol, doi: 10.1093/mr/roab098, 2021. [Online ahead of print]
35.	Chen H, Ishihara M, Horita N, Kazahari H, Ochiai R, Tanzawa S, Honda T, Ichikawa Y, Watanabe K, Seki N: Effect of Adjuvant and Palliative Chemotherapy in Large Cell Neuroendocrine Carcinoma of the Lung: A Systematic Review and Meta-Analysis. Cancers (Basel), 13: 5948, 2021.
36.	Tagami Y, Hara Y, Murohashi K, Nagasawa R, Nishikawa Y, Tanaka M, Aoki A, Tanaka K, Nakashima K, Watanabe K, Horita N, Kobayashi N, Yamamoto M, Kudo M, Okudela K, Kaneko T: Comparison of Clinical Features between the High and Low Serum KL-6 Patients with Acute Exacerbation of Interstitial Lung Diseases. Can Respir J, 2021: 9099802, 2021.
37.	Hamada N, Maeda A, Takase-Minegishi K, Kirino Y, Sugiyama Y, Namkoong H, Horita N, Yoshimi R, Nakajima H; YCU irAE Working Group: Incidence and Distinct Features of Immune Checkpoint Inhibitor-Related Myositis From Idiopathic Inflammatory Myositis: A Single-Center Experience With Systematic Literature Review and Meta-Analysis. Front Immunol, 12: 803410, 2021.
38.	Miyakawa K, Kubo S, Stanleyraj Jeremiah S, Go H, Yamaoka Y, Ohtake N, Kato H, Ikeda S, Mihara T, Matsuba I, Sanno N, Miyakawa M, Shinkai M, Miyazaki T, Ogura T, Ito S, Kaneko T, Yamamoto K, Goto A, Ryo A: Persistence of Robust Humoral Immune Response in Coronavirus Disease 2019 Convalescent Individuals Over 12 Months After Infection. Open Forum Infect Dis, 9: ofab626, 2021.
39.	小林信明, 高橋浩一郎, 浅井一久, 礒部威, 今泉和良, 大平徹郎, 長内忍, 川山智隆, 國近尚美, 小林和幸, 佐野博幸, 多賀谷悦子, 千葉弘文, 橋本直純, 須田隆文, 金子猛, 日本呼吸器学会将来計画委員会: 呼吸器内科医師の海外留学に関するアンケート調査. 日本呼吸器学会誌, 10:102-107.
40.	橋本恒, 小泉晴美, 金子彩美, 藤井裕明, 亀井克彦, 金子猛: 多剤併用療法で改善を得たAspergillus tubingensisによる慢性進行性肺アスペルギルス症の1例. 日本呼吸器学会誌, 10: 158-162.
41.	橋本恒, 渡邉恵介, 三宅暁夫, 田中克志, 中島健太郎, 原悠, 小林信明, 金子猛: 尋常性乾癬に合併した器質化肺炎が疑われた1例. 気管支学, 43:112-116, 2021.
42.	木村泰浩, 鄭慶鎬, 佐渡怜子, 宮沢直幹, 金子猛: ダサチニブによる薬剤性肺障害の1例. 日本呼吸器学会誌, 10: 277-282, 2021.
43.	荻窪まどか, 伊坂哲哉, 石川善啓, 禹哲漢, 利野靖, 益田宗孝, 松村舞依, 奥寺康司, 小林信明, 金子猛: 高齢者の肺Combined Large-Cell Neuroendocrine Carcinoma術後再発にアムルビシン単独投与の有効性が認められた1例. 癌と化学療法, 48: 681-683, 2021.
44.	庄内志織, 長澤遼, 原悠, 橋本恒, 奥寺康司, 金子猛: 喫煙関連間質性肺炎様変化を示した関節リウマチの2例. 日本呼吸器学会誌, 10: 487-493, 2021.

総説

1.	金子猛: 【特集: リハビリテーション診療の現場で悩む呼吸トラブル対策】Ⅱ.喀痰障害喀痰を生じる病態と喀痰診療のポイント. MEDICAL REHABILITATION, 257: 17-21. 2021.
2.	原悠, 金子猛：【特集: 慢性咳嗽-古い症状・新しい知見】咳のメカニズム. カレントテラピー, 39: 8-12, 2021.
3.	原悠, 長澤遼, 田上陽一, 金子猛:【内科医に必要な呼吸器診療のコツ】咳嗽・喀痰の診かたと薬物療法. 日本内科学会雑誌, 110: 1063-1070, 2021.
4.	原悠, 稲森正彦, 青木絢子, 田上陽一, 中島健太郎, 渡邉恵介, 堀田信之, 小林信明, 金子猛: 病棟実習の代替教育ツールとしてのオンライン方式JABSOM PBLの実践横浜市立大学医学部における試み. 横浜医学, 72: 89-92, 2021.
5.	長澤遼, 原悠, 金子猛: COPDの増悪の治療. 呼吸器内科, 39: 136-141, 2021.
6.	田上陽一, 原悠, 金子猛: 解説コロナ禍におけるCOPDの管理. 呼吸器内科, 39: 259-264, 2021.
7.	工藤誠：【特集: 呼吸管理FAQ-研修医からの質問270-】酸素療法低流量酸素療法. 救急・集中治療, 33(4): 1079-1084, 2021.
8.	釣木澤尚実, 押方智也子:【呼吸器症候群(第3版)～その他の呼吸器疾患を含めて～】Ⅳ アレルギー性肺疾患好酸球性多発血管炎性肉芽腫症. 別冊日本臨床領域別症候群シリーズ, 18: 84-90, 2021.
9.	釣木澤尚実: プロからプロへ好酸球性多発血管炎性肉芽腫症（EGPA）の治療のポイントは？日本医事新報, 5057: 49, 2021.
10.	釣木澤尚実, 押方智也子: 好酸球性多発血管炎性肉芽腫症. アレルギーの臨床, 41：293-296, 2021.
11.	釣木澤尚実: プロからプロへ牛肉アレルギーと交差反応について. 日本医事新報, 5071：44, 2021.

著書

1.	金子猛: ニューモシスチス肺炎. 今日の治療指針2021. 医学書院, 33-234, 2021.
2.	金子猛: Ⅱ．喀痰障害. 喀痰を生じる病態と喀痰診療のポイント. リハビリテーション診療の現場で悩む呼吸トラブル対策. 全日本病院出版会, 17-21, 2021, 1.
3.	金子猛: 6.喀痰の科学と喀嗽・喀痰の診療ガイドライン. 呼吸器疾患最新の治療2021-‘2022. 南江堂, 22-27, 2021.
4.	金子猛: ＜外部評価委員＞専門医のための遷延性・慢性咳嗽の診断と治療に関する指針. NPO法人日本咳嗽学会, 2021.

新聞・テレビ・雑誌等

1.	金子猛: 【特集: 私たち世代の持病対策最前線】痰が出る. 毎日が発見, 213: 90-91, 2021.
2.	金子猛: 読売新聞 2021年5月9日朝刊特集記事「呼吸の日　Withコロナ時代のぜん息治療～医師からのアドバイス～」

学会発行診療ガイドライン等